141 related articles for article (PubMed ID: 8908040)
1. Intestinal transplantation in children.
Langnas AN; Dhawan A; Antonson DL; Kaufman SS; Mack DR; Heffron TG; Fox IJ; Shaw BW; Vanderhoof JA
Transplant Proc; 1996 Oct; 28(5):2752. PubMed ID: 8908040
[No Abstract] [Full Text] [Related]
2. Immunosuppressive requirements for small bowel/liver transplantation.
McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086
[No Abstract] [Full Text] [Related]
3. Cholestatic liver disease after small bowel transplantation failure in children.
Colomb V; Goulet OJ; Revillon Y; Jan D; Brousse N; Rambaud C; De Potter S; Francois B; Sarnacki S; Ricour C
Transplant Proc; 1994 Jun; 26(3):1429. PubMed ID: 8029969
[No Abstract] [Full Text] [Related]
4. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
[No Abstract] [Full Text] [Related]
5. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E
Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845
[No Abstract] [Full Text] [Related]
6. Optimal immunosuppressive clinical regimen in liver transplantation.
Farges O; Samuel D; Bismuth H
Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838
[No Abstract] [Full Text] [Related]
7. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
Chen M; Wade J; Levy GA; Greig PD
Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
[No Abstract] [Full Text] [Related]
8. Triple drug maintenance therapy in renal transplantation.
Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A
Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343
[No Abstract] [Full Text] [Related]
9. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY
Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821
[No Abstract] [Full Text] [Related]
10. Clinical results of quadruple drug immunosuppression in liver transplantation.
Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S
Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
[No Abstract] [Full Text] [Related]
11. Sequential monitoring of immunoregulatory T cell subsets in renal transplantation.
Mestre M; González C; Griño JM; Valls A; Bonete J; Mané E; Corominas M; Bas J; Romeu A; Buendia E
Transplant Proc; 1992 Feb; 24(1):73-5. PubMed ID: 1539351
[No Abstract] [Full Text] [Related]
12. Immunosuppression is not related to the response to steroids in acute liver rejection.
Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M
Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830
[No Abstract] [Full Text] [Related]
13. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Lemmens HP; Langrehr JM; Blumhardt G; Lohmann R; Knoop M; Verschl J; Schattenfroh N; Neuhaus R; Hopf U; Bechstein WO
Transplant Proc; 1994 Dec; 26(6):3622-3. PubMed ID: 7527983
[No Abstract] [Full Text] [Related]
14. Cyclosporine Neoral in liver transplant recipients.
Levy G; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K; Grant D
Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930
[No Abstract] [Full Text] [Related]
15. Impact of cyclosporine dose on long-term outcome after heart transplantation.
Valantine H; Hunt S; Gamberg P; Miller J; Luikart H
Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848
[No Abstract] [Full Text] [Related]
16. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W
Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
[No Abstract] [Full Text] [Related]
17. ABO incompatible liver transplantation in children: a prospective approach.
Renard TH; Shimaoka S; Le Bherz D; Conlin C; Andrews WS
Transplant Proc; 1993 Apr; 25(2):1953-6. PubMed ID: 8470241
[No Abstract] [Full Text] [Related]
18. OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients.
Sommerauer JF; Atkison P; Howard J; Grant D; Wall W
Transplant Proc; 1994 Feb; 26(1):154-6. PubMed ID: 8108917
[No Abstract] [Full Text] [Related]
19. Clinical immunosuppression, lymphocyte subsets, and host defense mechanisms.
Guttmann RD
Transplant Proc; 1994 Aug; 26(4):1847. PubMed ID: 8066601
[No Abstract] [Full Text] [Related]
20. A miniature swine model for intestinal transplantation.
Takano K; Kosi M; Thomas D; Fuss I; Srikanth MS; Nio M; Parkman R; Atkinson J
Transplant Proc; 1992 Jun; 24(3):1081-2. PubMed ID: 1604525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
